• Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Jul 19 2022
  • Length: 10 mins
  • Podcast

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Listen for free

View show details

  • Summary

  • Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available